Skip to content
OpenCapital
Get started

Edwards Lifesciences EW Ratios & Valuation

Income StatementBalance SheetCash FlowRatiosSegments
QuarterlyAnnualTTM
YoYQoQ
SimplifiedDetailed
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Profitability
Gross margin77.9%-0.1pp78%-0.2pp78.2%-0.7pp78.9%-0.6pp79.5%0.0pp
Operating margin21.4%+0.5pp20.8%-3.4pp24.2%-1.6pp25.8%0.0pp25.8%+0.4pp
Net margin17.4%-0.3pp17.7%-5.6pp23.2%-49.7pp73%-2.8pp75.7%-1.0pp
EBITDA margin23.9%+0.5pp23.4%-3.5pp26.9%-1.6pp28.5%-0.1pp28.6%+0.4pp
Free cash flow margin17.3%-4.7pp22%———————
Returns
Return on equity10.7%+0.2pp10.6%-3.3pp13.9%-32.3pp46.1%-2.4pp48.5%-1.7pp
Return on assets8.3%+0.3pp8%-2.4pp10.4%-24.7pp35.2%-1.6pp36.7%-0.5pp
Return on invested capital13.7%+0.4pp13.3%-3.1pp16.4%-1.2pp17.6%-0.2pp17.8%-0.2pp
Efficiency
Asset turnover0.5×0.0×0.5×0.0×0.4×0.0×0.5×0.0×0.5×0.0×
Inventory turnover1.2×0.0×1.2×+0.1×1.1×0.0×1.1×+0.1×1×-0.1×
Liquidity
Current ratio4.4×+0.7×3.7×-0.3×4×-0.7×4.7×+0.2×4.5×+0.3×
Quick ratio3.6×+0.5×3.1×-0.2×3.3×-0.6×3.9×+0.2×3.7×+0.2×
Cash ratio1.7×+0.1×1.6×-0.1×1.7×-0.6×2.3×+0.1×2.3×+0.2×
Leverage
Debt-to-equity0.1×0.0×0.1×0.0×0.1×0.0×0.1×0.0×0.1×0.0×
Debt-to-assets0.1×0.0×0.1×0.0×0.1×0.0×0.1×0.0×0.1×0.0×
Net debt / EBITDA-1.2×+0.4×-1.6×-0.3×-1.3×+0.3×-1.6×0.0×-1.6×0.0×
Per Share
Book value per share$17.78+0.8%$17.65+1.3%$17.42-2.9%$17.94+4.1%$17.23+3.3%
Valuation
Market capitalization$46.17B-6.7%$49.47B+8.3%$45.66B+2.6%$44.49B+4.8%$42.46B-2.8%
Enterprise value$44.42B-6.0%$47.24B+8.2%$43.66B+4.2%$41.91B+4.7%$40.01B-3.1%
Price / earnings42.1×-4.0×46.1×+12.7×33.4×+22.7×10.7×+0.6×10.2×-0.3×
Price / sales7.3×-0.8×8.2×+0.4×7.8×-0.1×7.8×+0.1×7.7×-0.3×
Price / book4.5×-0.3×4.8×+0.3×4.5×+0.3×4.2×0.0×4.2×-0.2×
EV / EBITDA29.5×-3.8×33.2×+5.6×27.6×+1.7×25.9×+0.5×25.4×-1.6×
EV / sales7×-0.7×7.8×+0.4×7.4×0.0×7.4×+0.1×7.2×-0.3×
Free cash flow yield2.4%-0.3pp2.7%———————
Earnings yield2.4%+0.2pp2.2%-0.8pp3%-6.3pp9.3%-0.5pp9.8%+0.3pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Edwards Lifesciences's profit margins?
Edwards Lifesciences (EW) runs a 77.9% gross margin and a 21.4% operating margin, with a 17.4% net margin.
Where do Edwards Lifesciences's ratios come from?
Every ratio is computed from Edwards Lifesciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.